计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| rp147353-10μg |
10μg |
现货 ![]() |
| |
| rp147353-50μg |
50μg |
现货 ![]() |
| |
| rp147353-100μg |
100μg |
现货 ![]() |
| |
| rp147353-1mg |
1mg |
期货 ![]() |
|
| 产品名称 | Recombinant Human IL1 Receptor I/IL-1R-1 Protein |
|---|---|
| 别名 | 重组人 IL1 受体 I/IL-1R-1 蛋白 |
| 英文别名 | CD121 antigen-like family member A | EC 3.2.2.6 | IL-1R-1 | IL-1R-alpha | IL-1RT1 | IL-1RT-1 | Interleukin-1 receptor alpha | Interleukin-1 receptor type I | p80 |
| 规格或纯度 | ActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥95%(SDS-PAGE) |
| 产品介绍 |
Purity |
| 生物活性 | Measured by its ability to inhibit proliferation using D10.G4.1 mouse helper T cells. The ED50 for this effect is 0.2-1.0 µg/mL with human IL-1 beta. |
| 内毒素水平 | <0.1 EU/μg |
| 表达系统 | HEK293 |
| 种属 | 人(Human) |
| 氨基酸 | 21-332 aa |
| 序列 | DKCKEREEKIILVSSANEIDVRPCPLNPNEHKGTITWYKDDSKTPVSTEQASRIHQHKEKLWFVPAKVEDSGHYYCVVRNSSYCLRIKISAKFVENEPNLCYNAQAIFKQKLPVAGDGGLVCPYMEFFKNENNELPKLQWYKDCKPLLLDNIHFSGVKDRLIVMNVAEKHRGNYTCHASYTYLGKQYPITRVIEFITLEENKPTRPVIVSPANETMEVDLGSQIQLICNVTGQLSDIAYWKWNGSVIDEDDPVLGEDYYSVENPANKRRSTLITVLNISEIESRFYKHPFTCFAKNTHGIDAAYIQLIYPVTHHHHHH |
| 纯度 | ≥95% (SDS-PAGE) |
| 蛋白标签 | C-His |
| 无载体 | Yes |
| 无动物源 | Yes |
| Accession # | P14778 |
| 来源 | 重组表达 |
| 预测分子量 | 55 kDa |
| 物理形态 | 冻干(Lyophilized) |
|---|---|
| 储存缓冲液 | Lyophilized from 10mM PBS, 5% trehalose, 5% mannitol, pH 7.4 |
| 复溶 | Reconstitute in sterile water to a concentration of 0.1-0.5 mg/ml. |
| 储存温度 | -20°C储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -20~-80℃ 下可保存 1 年以上。收货后建议分装。避免冷冻/解冻循环。 |
| 分子类型 | 蛋白质 |
Recombinant Human IL1 Receptor I/IL-1R-1 Protein (rp147353) - SDS-PAGE
3 μg/lane of Recombinant Human IL1 Receptor I/IL-1R-1 Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing the band at 50 - 60 kDa under reducing condition and 45 - 55 kDa under non-reducing condition.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | rp147353 | |
| 分析证书 | rp147353 | |
| 分析证书 | rp147353 |
| 1. Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenberg SP. (1991) Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils.. J Biol Chem, 266 (30): (20311-5). [PMID:1834644] |
| 2. Schreuder H, Tardif C, Trump-Kallmeyer S, Soffientini A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S, Barrett RW. (1997) A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.. Nature, 386 (6621): (194-200). [PMID:9062194] |
| 3. Haile PA, Votta BJ, Marquis RW, Bury MJ, Mehlmann JF, Singhaus Jr R, Charnley AK, Lakdawala AS, Convery MA, Lipshutz DB et al.. (2016) The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase.. J Med Chem, 59 (10): (4867-80). [PMID:27109867] |
| 4. Kovalchin J, King B, Masci A, Hopkins E, Fry J, Hou J, Li C, Tenneson K, Weber S, Wolfe G et al.. (2018) Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases.. Eye Contact Lens, 44 (3): (170-181). [PMID:28727604] |
| 5. Giri JG, Wells J, Dower SK, McCall CE, Guzman RN, Slack J, Bird TA, Shanebeck K, Grabstein KH, Sims JE et al.. (1994) Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.. J Immunol, 153 (12): (5802-9). [PMID:7989776] |
| 6. Haile PA, Casillas LN, Votta BJ, Wang GZ, Charnley AK, Dong X, Bury MJ, Romano JJ, Mehlmann JF, King BW et al.. (2019) Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases.. J Med Chem, 62 (14): (6482-6494). [PMID:31265286] |
| 7. Zhang L, Shi L, Soars SM, Kamps J, Yin H.. (2018) Discovery of Novel Small-Molecule Inhibitors of NF-κB Signaling with Antiinflammatory and Anticancer Properties.. J Med Chem, 61 (14): (5881-5899). [PMID:29870245] [10.1021/acs.jmedchem.7b01557] |
| 8. Knoepfel T, Nimsgern P, Jacquier S, Bourrel M, Vangrevelinghe E, Glatthar R, Behnke D, Alper PB, Michellys PY, Deane J, Junt T, Zipfel G, Limonta S, Hawtin S, Andre C, Boulay T, Loetscher P, Faller M, Blank J, Feifel R, Betschart C.. (2020) Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.. J Med Chem, 63 (15): (8276-8295). [PMID:32786235] [10.1021/acs.jmedchem.0c00130] |
| 9. Sims, J E JE and 6 more authors.. (1989) Cloning the interleukin 1 receptor from human T cells.. Proceedings of the National Academy of Sciences of the United States of America, [PMID:2530587] |
| 10. Chua, A O AO and Gubler, U U.. (1989) Sequence of the cDNA for the human fibroblast type interleukin-1 receptor.. Nucleic acids research, (11): [PMID:2532321] |
| 11. Vigers, G P GP, Anderson, L J LJ, Caffes, P P and Brandhuber, B J BJ.. (1997) Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.. Nature, (13): [PMID:9062193] |
| 12. Huang, J J, Gao, X X, Li, S S and Cao, Z Z.. (1997) Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein.. Proceedings of the National Academy of Sciences of the United States of America, (25): [PMID:9371760] |
| 13. Vannier, E E and 6 more authors.. (1999) Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.. European cytokine network, [PMID:10210771] |
| 14. Tominaga, K K and 7 more authors.. (2000) IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.. International immunology, [PMID:10653850] |
| 15. Vigers, G P GP, Dripps, D J DJ, Edwards, C K CK and Brandhuber, B J BJ.. (2000) X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1.. The Journal of biological chemistry, (24): [PMID:10903327] |
| 16. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ.. (2002) TTD: Therapeutic Target Database.. Nucleic acids research, (1): [PMID:11752352] |
| 17. Vamvakopoulos, Joannis J, Green, Colin C and Metcalfe, Su S.. (2002) Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist.. European journal of immunology, [PMID:12355453] |
| 18. and Dayer, J M JM.. (2003) The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.. Rheumatology (Oxford, England), [PMID:12817089] |
| 19. Hillier, Ladeana W LW and 121 more authors.. (2005) Generation and annotation of the DNA sequences of human chromosomes 2 and 4.. Nature, (7): [PMID:15815621] |
| 20. Do, Herve H and 12 more authors.. (2006) Exhaustive genotyping of the interleukin-1 family genes and associations with AIDS progression in a French cohort.. The Journal of infectious diseases, (1): [PMID:17083033] |
| 21. So, Alexander A, De Smedt, Thibaut T, Revaz, Sylvie S and Tschopp, Jürg J.. (2007) A pilot study of IL-1 inhibition by anakinra in acute gout.. Arthritis research & therapy, [PMID:17352828] |
| 22. Tang, Ying-hong YH, Zhang, Shu-ping SP, Liang, Yan Y and Deng, Chang-qing CQ.. (2007) [Effects of Panax notoginseng saponins on mRNA expressions of interleukin-1 beta, its correlative factors and cysteinyl-aspartate specific protease after cerebral ischemia-reperfusion in rats].. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, [PMID:17498496] |